Young researcher designs protector for people with Peritoneal Dialysis

A lack of comfortable products for the safety of patients requiring peritoneal dialysis, administered to clean waste products from the blood when the kidneys fail, drove a student of the Higher Technological Institute of Choapas, Veracruz in the east coast of México, to develop an ergonomic support allowing catheters inserted through the abdominal wall to remain in place and protected from the invasion of microorganisms.

"The support, called DIAL, is a type of belt manufactured with cotton and lightweight materials that prevent moisture retention and accumulation of bacteria, as well as being comfortable for skin contact," says Adriana Rodríguez Chan, leader the project.

She explains that the idea for the protector belt was born of the need to provide support to a sector of the population that has not been taken into account, people with kidney failure receiving .

"While visiting different hospitals, we saw that many people have the catheter out or sometimes being supported with the belt buckle, which is very dangerous, because it involves a high risk of injury and infection," she notes. She adds that she has family requiring such treatment who could not find a safe, comfortable product to cover and hold the catheter in place.

After creating the ergonomic support DIAL and verifying its effectiveness in patients, Rodríguez Chan wants her company to be nationally recognized in the distribution and sale of materials for the protection and safety of patients with renal insufficiency. In this regard, she stresses that the product is unique in the market, economic and its mass production will help to create new jobs.

Notably, peritoneal dialysis, in addition to cleaning the blood of waste products, removes extra fluids and controls the body's chemistry, using one of the body's natural filters, the peritoneal membrane lining the abdomen.

Once the is inserted in that area, across the abdominal region, it is filled with a solution. The waste and extra fluid from the blood are filtered through the peritoneum and collected in the solution, which must remain for 30 to 45 minutes inside the body. An n average of four to five exchanges of solution are required per day, resulting in the ergonomic DIAL being very helpful for patients.

add to favorites email to friend print save as pdf

Related Stories

Fight against organ failure advances

Jan 13, 2014

(Medical Xpress)—The findings of a 20-year project undertaken by scientists committed to developing improved treatments for chronic kidney disease reveal a significant advance in our understanding of organ ...

Snapshot of dialysis: Who's getting treated at home?

Feb 02, 2012

Home-based dialysis treatments are on the rise in both the developing and developed worlds, but developed countries appear to be turning to them less often, according to a study appearing in an upcoming issue of the Journal of ...

Recommended for you

S.Korea detects second foot-and-mouth case

2 hours ago

South Korea on Monday reported its second case of foot-and-mouth disease in less than a week, triggering fearful memories of a devastating 2011 outbreak that forced the culling of millions of livestock.

Ebola kills Liberian doctor, 2 Americans infected

2 hours ago

(AP)—One of Liberia's most high-profile doctors has died of Ebola, officials said Sunday, and an American physician was being treated for the deadly virus, highlighting the risks facing health workers trying ...

Hepatitis C virus genotype 1 is most prevalent worldwide

3 hours ago

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journa ...

1 in 3000 blood donors in England infected with hepatitis E

3 hours ago

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around ...

Biologic treatments for RA carry similar infection risk

3 hours ago

(HealthDay)—The risk of hospitalized bacterial infections in older rheumatoid arthritis (RA) patients is similar for rituximab or abatacept compared to etanercept, although it is higher for infliximab, ...

New oral drug regimens cure hardest-to-treat hepatitis C

3 hours ago

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according ...

User comments